EUVIMEDEUVIMED entdecken
Crossref

Advances in urinary biomarker research of synthetic cannabinoids

Ziteng Wang, Eric Yu Quan Leow, Hooi Yan Moy, Eric Chun Yong Chan

Advances in Clinical Chemistry · 2023

DOI: 10.1016/bs.acc.2023.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Chemistry, 2023. Verfasst von Ziteng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Body Fluids, Illicit Drugs, Cannabinoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New psychoactive substances (NPS) are chemical compounds designed to mimic the action of existing illicit recreational drugs. Synthetic cannabinoids (SCs) are a subclass of NPS which bind to the cannabinoid receptors, CB1 and CB2, and mimic the action of cannabis. SCs have dominated recent NPS seizure reports worldwide. While urine is the most common matrix for drug-of-abuse testing, SCs undergo extensive Phase I and Phase II metabolism, resulting in almost undetectable parent compounds in urine samples. Therefore, the major urinary metabolites of SCs are usually investigated as surrogate biomarkers to identify their consumption. Since seized urine samples after consuming novel SCs may be unavailable in a timely manner, human hepatocytes, human liver microsomes and human transporter overexpressed cell lines are physiologically-relevant in vitro systems for performing metabolite identification, metabolic stability, reaction phenotyping and transporter experiments to establish the disposition of SC and its metabolites. Coupling these in vitro experiments with in vivo verification using limited authentic urine samples, such a two-pronged approach has proven to be effective in establishing urinary metabolites as biomarkers for rapidly emerging SCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body FluidsIllicit DrugsCannabinoidsHumansBiomarkers

Stichwörter der Autor:innen

Metabolic stabilityMetabolismMetabolite identificationNew psychoactive substances (NPS)PharmacokineticsReaction phenotypingSynthetic cannabinoids (SCs)Urinary biomarkers

Substanzen

BiomarkersIllicit DrugsCannabinoids

Autor:innen und Institutionen

  • Department of Pharmacy, National University of Singapore, Singapore, Singapore.
  • Analytical Toxicology Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore, Singapore.
  • Department of Pharmacy, National University of Singapore, Singapore, Singapore. Electronic address: phaccye@nus.edu.sg.

Zitieren

APA

Wang, Z., Leow, E. Y. Q., Moy, H. Y., & Chan, E. C. Y. (2023). Advances in urinary biomarker research of synthetic cannabinoids. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2023.03.004

Vancouver

Wang Z, Leow EYQ, Moy HY, Chan ECY. Advances in urinary biomarker research of synthetic cannabinoids. Advances in Clinical Chemistry. 2023. doi:10.1016/bs.acc.2023.03.004

BibTeX
@article{Wang2023,
  author = {Wang, Ziteng and Leow, Eric Yu Quan and Moy, Hooi Yan and Chan, Eric Chun Yong},
  title = {Advances in urinary biomarker research of synthetic cannabinoids},
  journal = {Advances in Clinical Chemistry},
  year = {2023},
  doi = {10.1016/bs.acc.2023.03.004}
}
Kostenlos starten →